The Board

Gary Glass


Gary is a highly successful mid-cap private equity executive with Board experience across a broad range of industries and stages of development. A business angel and investor in Sarissa, Gary brings significant expertise & experience to support the management team.

Dr Everard Mascarenhas

Chief Executive Officer

Everard is an experienced commercial manager, having built 2 start-ups from concept through to revenue, managed product development programmes and been a VC investment executive. Everard has also advised SME & multi-nationals on strategy, commercialising R&D, IPOs & M&A transactions and is an NXD on VC backed ventures.

Professor Nicholas Dale

Chief Technology Officer

Nick is the founder of Sarissa Biomedical and inventor of Sarissa’s biosensor technology. He is the Ted Pridgeon Professor of Neuroscience at Warwick University, has over a 100 international scientific publications and is the recipient of a Wolfson Research Merit Award from the Royal Society.

Dr Quentin Compton-Bishop

Non Executive Director

Quentin is currently CEO of Warwick Ventures and Director of several Warwick spin-outs. Prior to Warwick, he helped establish and led a number of early-stage technology companies operating in a wide range of sectors.

Professor Bruno Frenguelli

Non Executive Director

Founder’s Director and a leading neuroscientist, Bruno has research interests in stroke, epilepsy & traumatic brain injury. Bruno, together with Nick, made the first measurements of purine release during in vitro models of stroke.


  • Mercia Fund
  • Welcome Trust
  • Warwick University
  • Family Office
  • HNW / Angel Investors
  • Management & Founders